TABLE OF CONTENTS

Volume 75, Issue 112s (February 2009)

HUS/TTP Update 2008 Symposium

Top

Introduction

HUS/TTP update: 2008

William F Clark

Kidney Int 75: S1-S3; doi:10.1038/ki.2008.607

Top

Reviews

Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome

Mohamed A Karmali

Kidney Int 75: S4-S7; doi:10.1038/ki.2008.608

The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989–2007)

James N George

Kidney Int 75: S8-S10; doi:10.1038/ki.2008.609

Mechanisms of microvascular thrombosis in thrombotic thrombocytopenic purpura

Han-Mou Tsai

Kidney Int 75: S11-S14; doi:10.1038/ki.2008.610

Mechanism of microthrombosis in HUS

Gail A Rock and William F Clark

Kidney Int 75: S15-S16; doi:10.1038/ki.2008.611

Verotoxin biology: molecular events in vascular endothelial injury

Tania N Petruzziello, Imtiaz A Mawji, Mukarram Khan and Philip A Marsden

Kidney Int 75: S17-S19; doi:10.1038/ki.2008.612

Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008)

Anaadriana Zakarija, Hau C Kwaan, Joel L Moake, Nicholas Bandarenko, Dilip K Pandey, June M McKoy, Paul R Yarnold, Dennis W Raisch, Jeffrey L Winters, Thomas J Raife, John F Cursio, Thanh Ha Luu, Elizabeth A Richey, Matthew J Fisher, Thomas L Ortel, Martin S Tallman, X Long Zheng, Masanori Matsumoto, Yoshihiro Fujimura and Charles L Bennett

Kidney Int 75: S20-S24; doi:10.1038/ki.2008.613

Experiences with HUS in Canada: what have we learned about childhood HUS in Canada?

Peter N McLaine, Peter C Rowe and Elaine Orrbine

Kidney Int 75: S25-S28; doi:10.1038/ki.2008.614

Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis

Phillip I Tarr

Kidney Int 75: S29-S32; doi:10.1038/ki.2008.615

Factors that led to the Walkerton tragedy

Marina I Salvadori, Jessica M Sontrop, Amit X Garg, Louise M Moist, Rita S Suri and William F Clark

Kidney Int 75: S33-S34; doi:10.1038/ki.2008.616

An outbreak of diarrhea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic

Douglas G Matsell and Colin T White

Kidney Int 75: S35-S37; doi:10.1038/ki.2008.628

Renal prognosis of toxigenic Escherichia coli infection

Amit X Garg, Marina Salvadori, Louise M Moist, Rita S Suri and William F Clark

Kidney Int 75: S38-S41; doi:10.1038/ki.2008.617

Post-infectious irritable bowel syndrome following water contamination

John K Marshall

Kidney Int 75: S42-S43; doi:10.1038/ki.2008.618

Relationship between Escherichia coli O157:H7 and diabetes mellitus

Rita S Suri, Jeffrey L Mahon, William F Clark, Louise M Moist, Marina Salvadori and Amit X Garg

Kidney Int 75: S44-S46; doi:10.1038/ki.2008.619

Risk of pregnancy-related hypertension within five years of exposure to bacteria-contaminated drinking water

Louise M Moist, Jessica M Sontrop, Amit X Garg, William F Clark, Rita S Suri, Marina Salvadori, Robert J Gratton and Jennifer Macnab

Kidney Int 75: S47-S49; doi:10.1038/ki.2008.620

TTP/HUS: observational studies generate hypotheses that lead to randomized controlled trials

William F Clark, Brian R Forzley, Jessica M Sontrop, Albert Kadri, Louise M Moist, Rita S Suri, Marina S Salvadori and Amit X Garg

Kidney Int 75: S50-S51; doi:10.1038/ki.2008.621

The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989–2007

James N George

Kidney Int 75: S52-S54; doi:10.1038/ki.2008.622

A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura

Stephen R Foley, Kathryn Webert, Donald M Arnold, Gail A Rock, William F Clark, David Barth and David M Sutton Members of the Canadian Apheresis Group (CAG)

Kidney Int 75: S55-S58; doi:10.1038/ki.2008.629

TTP/HUS and prognosis: the syndrome and the disease(s)

Brian R Forzley and William F Clark

Kidney Int 75: S59-S61; doi:10.1038/ki.2008.623

Treatment options for HUS secondary to Escherichia coli O157:H7

Martin Bitzan

Kidney Int 75: S62-S66; doi:10.1038/ki.2008.624

Extra navigation

.
ADVERTISEMENT